PREPIDIL (dinoprostone) by Pfizer is hormone. First approved in 1992.
Drug data last refreshed 2d ago
PREPIDIL (dinoprostone) is a prostaglandin analog administered as an endocervical gel for cervical ripening and labor induction in pregnant women. It works by stimulating prostaglandin F2α production, which softens cervical tissue and sensitizes the uterus to oxytocin without directly inducing contractions in early labor stages. Dinoprostone mimics the natural hormone secreted by fetal membranes and placenta during pregnancy.
Product approaching loss of exclusivity with moderate competitive pressure (30/100); team focus likely shifting toward lifecycle management and retention strategies.
hormone. In pregnancy, dinoprostone is secreted continuously by the fetal membranes and placenta and plays an important role in the final events leading to the initiation of labor including cervical ripening. Dinoprostone stimulates the production of prostaglandin F 2α ( PGF 2α), which sensitizes…
Prostaglandin Analog
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
An RCT of a Synthetic Osmotic Cervical Dilator for Induction of Labour in Comparison to Dinoprostone Vaginal insErt
Efficacy of Induction of Labor on Term Using a Double Balloon Catheter Compared to Dinoprostone Vaginal-insert
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction
Worked on PREPIDIL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
PREPIDIL offers limited growth career opportunities given its LOE-approaching status and zero linked job openings, making it a defensive rather than expansive product assignment. Roles tend to focus on protecting market share, managing generic transition, and maintaining physician relationships in obstetric settings.